A striking observation from Charles Schwab’s On Investing podcast episode “Concentration Risk Meets Diversification Reality” ...

As it prepared to announce its schedule at the Disney upfront on Tuesday in New York, ABC noted its cross-platform broadcast ...

Veeam CEO Anand Eswaran talked with CRN about the VeeamON 2026 program, the importance of working with the channel on AI ...

Isomorphic Labs, an artificial intelligence-driven drug discovery company, said on Wednesday it has raised $2.1 billion in its latest funding round led ​by existing investor Thrive Capital. The ...

Do you want to know the best way to invest in the next big thing? Looking at what the so-called "smart money" is doing is a ...

Over the past year, Alphabet Inc. has gone from an artificial intelligence afterthought to the one firm in the market with ...

This partnership, which will operate in parts of Charlotte, is the first between the Alphabet-backed Wing and a national QSR ...

If any proof was needed that big money is still available for AI drug development, look no further than the ten-figure series B hauled in by Isomorphic Labs. The London-based AI drug discovery firm ...

The Trump-era rally is alive, well, and could bring markets to more elevated heights as we move through the summer months. Undoubtedly, not everyone is bullish on stocks at fresh highs, especially ...

Closing the gap: Alphabet’s value has climbed to $4.8 trillion after a sharp rally, narrowing the difference with Nvidia’s $5.2 trillion market cap. AI-powered diversity: With search, cloud, YouTube, ...

Anthropic is rumored to be circling a $200 billion deal with Google Cloud.

Google is negotiating with SpaceX and additional rocket providers to deploy orbital data centers Project Suncatcher targets the deployment of two test satellites before early 2027 Elon Musk’s SpaceX ...